樂觀
$5.42
情境價格
$1.770
+0.030 (+1.72%)收盤時
Clarivate Plc is a provider of transformative intelligence. The Company offers intelligence solutions, workflow solutions, and tech-enabled services to its customers. Its Intelligence solutions include up-to-date knowledge assets, combining data, structured taxonomies, and analytical models that transform complex information into actionable insights powered by a combination of artificial intelligence (AI)-enabled software and human expertise. It operates through two segments, which include Academia & Government (A&G), and Intellectual Property (IP). The Academia & Government segment connects trusted content, responsible technology, and editorial expertise to fuel academic success and advance national outcomes for institutions and users globally. The Intellectual Property segment provides intellectual property data, software, and helps companies drive innovation, law firms achieve practice excellence, and organizations manage and protect critical intellectual property assets.
Clarivate PLC (CLVT) is a good buy right now due to its recent strategic sale of the Life Sciences & Healthcare segment for $600 million, which is expected to enhance its focus and profitability. The current price of $1.61 is significantly below the analyst price target of $5 from Stifel, indicating a potential upside of over 200%. Additionally, the stock has shown a positive 5-day change of +8.78%, suggesting a recent upward momentum. However, the main risk is the company's substantial net loss of $268.6 million in Q2 2026, which reflects ongoing profitability challenges.
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Sterne Kessler Partners with Clarivate to Develop AI-Enhanced Patent Workflow Solutions

Clarivate Completes $600 Million Sale of Life Sciences & Healthcare Segment

Clarivate Completes $600 Million Sale of Life Sciences & Healthcare Segment

Clarivate Completes Sale of Life Sciences & Healthcare Segment for $600 Million

Clarivate Completes Cash Tender Offer for Senior Secured Notes
Clarivate Plc is a provider of transformative intelligence. The Company offers intelligence solutions, workflow solutions, and tech-enabled services to its customers. Its Intelligence solutions include up-to-date knowledge assets, combining data, structured taxonomies, and analytical models that transform complex information into actionable insights powered by a combination of artificial intelligence (AI)-enabled software and human expertise. It operates through two segments, which include Academia & Government (A&G), and Intellectual Property (IP). The Academia & Government segment connects trusted content, responsible technology, and editorial expertise to fuel academic success and advance national outcomes for institutions and users globally. The Intellectual Property segment provides intellectual property data, software, and helps companies drive innovation, law firms achieve practice excellence, and organizations manage and protect critical intellectual property assets. It operates in the Industrials sector (SERVICES-COMPUTER PROCESSING & DATA PREPARATION industry).
Clarivate PLC (CLVT) is a good buy right now due to its recent strategic sale of the Life Sciences & Healthcare segment for $600 million, which is expected to enhance its focus and profitability. The current price of $1.61 is significantly below the analyst price target of $5 from Stifel, indicating a potential upside of over 200%. Additionally, the stock has shown a positive 5-day change of +8.78%, suggesting a recent upward momentum. However, the main risk is the company's substantial net loss of $268.6 million in Q2 2026, which reflects ongoing profitability challenges.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。